• 1
    Thornberg E, Thiringer K, Odeback A, Milsom I. Birth asphyxia: Incidence, clinical course and outcome in a Swedish population. Acta Paediatr 1995; 84: 927932.
  • 2
    Nordstrom L, Arulkumaran S. Intrapartum fetal hypoxia and biochemical markers: A review. Obstet Gynecol Surv 1998; 53: 645657.
  • 3
    Shen XL, Lin CJ, Han LL, Lin L, Pan L, Pu XD. Assessment of ischemia-modified albumin levels for emergency room diag nosis of acute coronary syndrome. Int J Cardiol 2011; 149: 296298.
  • 4
    Gunduz A, Turedi S, Mentese A et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008; 26: 874878.
  • 5
    Sadler PJ, Tucker A, Viles JH. Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+. Eur J Biochem 1994; 220: 193200.
  • 6
    Baschat AA. Fetal responses to placental insufficiency: An update. BJOG 2004; 111: 10311041.
  • 7
    Botsis D, Vrachnis N, Christodoulakos G. Doppler assessment of the intrauterine growth-restricted fetus. Ann N Y Acad Sci 2006; 1092: 297303.
  • 8
    Committee on Fetus and Newborn, American Academy of Pediatrics, Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. Use and abuse of the Apgar score. Pediatrics 1996; 98: 141142.
  • 9
    Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IXXIV.
  • 10
    Kaymak O, Iskender CT, Ustunyurt E, Yildiz Y, Doganay M, Danisman N. Retrospective evaluation of perinatal outcome in women with mild gestational hyperglycemia. J Obstet Gynaecol Res 2011; 37: 986991.
  • 11
    Amini SB, Catalano PM, Hirsch V, Mann LI. An analysis of birth weight by gestational age using a computerized perinatal data base, 1975–1992. Obstet Gynecol 1994; 83: 342352.
  • 12
    Bahado-Singh RO, Kovanci E, Jeffres A et al. The Doppler cerebroplacental ratio and perinatal outcome in intrauterine growth restriction. Am J Obstet Gynecol 1999; 180: 750756.
  • 13
    Ozeren M, Dinc H, Ekmen U, Senekayli C, Aydemir V. Umbilical and middle cerebral artery Doppler indices in patients with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1999; 82: 1116.
  • 14
    Hadlock FP, Harrist RB, Carpenter RJ, Deter RL, Park SK. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements. Radiology 1984; 150: 535540.
  • 15
    Bower S, Vyas S, Campbell S, Nicolaides KH. Color Doppler imaging of the uterine artery in pregnancy: Normal ranges of impedance to blood flow, mean velocity and volume of flow. Ultrasound Obstet Gynecol 1992; 2: 261265.
  • 16
    Wladimiroff JW, vd Wijngaard JA, Degani S, Noordam MJ, van Eyck J, Tonge HM. Cerebral and umbilical arterial blood flow velocity waveforms in normal and growth-retarded pregnancies. Obstet Gynecol 1987; 69: 705709.
  • 17
    Odibo AO, Riddick C, Pare E, Stamilio DM, Macones GA. Cerebroplacental Doppler ratio and adverse perinatal outcomes in intrauterine growth restriction: Evaluating the impact of using gestational age-specific reference values. J Ultrasound Med 2005; 24: 12231228.
  • 18
    Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: A marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod 2007; 22: 20292032.
  • 19
    Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009; 88: 479482.
  • 20
    Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod 2008; 23: 803806.
  • 21
    Ustün Y, Engin-Ustün Y, Oztürk O, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in pre-eclampsia. J Matern Fetal Neonatal Med 2011; 24: 418421.
  • 22
    Dekker GA, Sibai BM. Etiology and pathogenesis of pre-eclampsia: Current concepts. Am J Obstet Gynecol 1998; 179: 13591375.
  • 23
    van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and pre-eclampsia. Hypertens Pregnancy 2008; 27: 159167.
  • 24
    Gugliucci A, Hermo R, Monroy C, Numaguchi M, Kimura S. Ischemia-modified albumin levels in cord blood: A case- control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005; 362: 155160.
  • 25
    Ma SG, Yu WN, Jin Y, Hong B, Hu W. Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus. Gynecol Endocrinol 2012; 28: 837840.
  • 26
    Ukinc K, Eminagaoglu S, Ersoz HO et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: Ischemia-modified albumin. Endocrine 2009; 36: 425432.
  • 27
    Kaefer M, Piva SJ, De Carvalho JA et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem 2010; 43: 450454.
  • 28
    Iacovidou N, Briana DD, Boutsikou M et al. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008; 2008: 523081.
  • 29
    Davis JM, Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 2010; 15: 191195.